Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical resiniferatoxin for refractory idiopathic detrusor overactivity
ACTRN12612000598886Phase 4Active, not recruiting
- Sponsor
- Pelvic Floor Unit Research Fund
- Start
- May 2004
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of resiniferatoxin in idiopathic detrusor overactivity (IDO), sponsored by Pelvic Floor Unit Research Fund. Primary endpoints: Frequency volume chart, International Consultation on Incontinence Questionnaire and 1 more. Started May 2004; status: active, not recruiting.
02
Drugs
resiniferatoxin
03
Conditions
idiopathic detrusor overactivity (IDO)
Beyond the preview
Go deeper on ACTRN12612000598886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000598886.